* Foamix announces completion of patient enrollment in phase
3 acne trials for Minocycline Foam FMX101
The post BRIEF-Foamix announces completion of patient enrollment in phase 3 acne trials for Minocycline Foam FMX101 appeared first on NASDAQ.
BRIEF-Foamix announces completion of patient enrollment in phase 3 acne trials for Minocycline Foam FMX101
